Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway

Jiang,Jiayi; Li,You; Jiang,Zheng

doi:10.3892/or.2019.7126

Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway

Authors:
- Jiayi Jiang
- You Li
- Zheng Jiang
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: April 17, 2019 https://doi.org/10.3892/or.2019.7126
Pages: 3281-3291
Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is one of the most common tumor types of the digestive tract. Its incidence and mortality rates are among the highest of all gastrointestinal tumor types. The expression of leucine zipper downregulated in cancer 1 (LDOC1) is decreased in numerous cancer types. In the present study, the aim was to investigate the role of LDOC1 and determine the potential molecular mechanisms of its action in CRC. The expression of LDOC1 in CRC tissues and adjacent normal tissues was detected by reverse transcription‑quantitative polymerase chain reaction and immunohistochemistry. LDOC1 expression in four CRC cell lines, compared with normal colorectal tissue, was determined by reverse transcription‑ polymerase chain reaction (RT‑PCR), and two cell lines with relatively low expression were screened. Human LDOC1 cDNA was inserted into a lentiviral vector, and transfected into HCT‑116 and Caco2 cell lines. The transfection efficiency was identified by RT‑PCR and western blot analysis. Cell proliferation was detected by Cell Counting Kit‑8 and colony formation assays. Cell cycle and apoptosis were detected by flow cytometry assay. Migration and invasion were assessed using Transwell and Matrigel assays, respectively. Additionally, whether LDOC1 regulates the Wnt/β‑catenin pathway was investigated by western blot analysis, and the expression and localization of β‑catenin in CRC cells were demonstrated by cellular immunofluorescence. LDOC1 expression was downregulated in CRC tissues and cells. LDOC1 overexpression inhibited cell proliferation, migration and invasion, but promoted cells apoptosis. Furthermore, LDOC1 downregulated the Wnt/β‑catenin pathway in CRC. In conclusion, LDOC1 is a tumor suppressor in CRC and it inhibits cell proliferation and promotes cell apoptosis. Additionally, it inhibits CRC cell metastasis by downregulating the Wnt/β‑catenin signaling pathway.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A and Jemal A: Colorectal cancer statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
3	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
4	Luo Y, Tsuchiya KD, Il Park D, Fausel R, Kanngurn S, Welcsh P, Dzieciatkowski S, Wang J and Grady WM: RET is a potential tumor suppressor gene in colorectal cancer. Oncogene. 32:2037–2047. 2013. View Article : Google Scholar : PubMed/NCBI
5	Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T and Yamaguchi K: Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett. 140:227–234. 1999. View Article : Google Scholar : PubMed/NCBI
6	Zhao S, Wang Q, Li Z, Ma X, Wu L, Ji H and Qin G: LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma. J Exp Clin Cancer Res. 34:1462015. View Article : Google Scholar : PubMed/NCBI
7	Lee CH, Pan KL, Tang YC, Tsai MH, Cheng AJ, Shen MY, Cheng YM, Huang TT and Lin P: LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation. Oncotarget. 6:25188–25201. 2015.PubMed/NCBI
8	Riordan JD and Dupuy AJ: Domesticated transposable element gene products in human cancer. Mob Genet Elements. 3:e266932013. View Article : Google Scholar : PubMed/NCBI
9	Camões MJ, Paulo P, Ribeiro FR, Barros-Silva JD, Almeida M, Costa VL, Cerveira N, Skotheim RI, Lothe RA, Henrique R, et al: Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. PLoS One. 7:e498192012. View Article : Google Scholar : PubMed/NCBI
10	Inoue M, Takahashi K, Niide O, Shibata M, Fukuzawa M and Ra C: LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett. 579:604–608. 2005. View Article : Google Scholar : PubMed/NCBI
11	Griesinger AM, Witt DA, Grob ST, Georgio Westover SR, Donson AM, Sanford B, Mulcahy Levy JM, Wong R, Moreira DC, DeSisto JA, et al: NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma. Neuro Oncol. 19:1350–1360. 2017. View Article : Google Scholar : PubMed/NCBI
12	Thoompumkal IJ, Rehna K, Anbarasu K and Mahalingam S: Leucine zipper down-regulated in cancer-1 (LDOC1) interacts with guanine nucleotide binding protein-like 3-like (GNL3L) to modulate nuclear factor-kappa B (NF-κB) signaling during cell proliferation. Cell Cycle. 15:3251–3267. 2016. View Article : Google Scholar : PubMed/NCBI
13	Nagasaki K, Schem C, von Kaisenberg C, Biallek M, Rösel F, Jonat W and Maass N: Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer. 105:454–458. 2003. View Article : Google Scholar : PubMed/NCBI
14	Buchholtz ML, Brüning A, Mylonas I and Jückstock J: Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells. Arch Gynecol Obstet. 290:149–154. 2014. View Article : Google Scholar : PubMed/NCBI
15	Buchholtz ML, Jückstock J, Weber E, Mylonas I, Dian D and Brüning A: Loss of LDOC1 expression by promoter methylation in cervical cancer cells. Cancer Invest. 31:571–577. 2013. View Article : Google Scholar : PubMed/NCBI
16	Yong BC, Lu JC, Xie XB, Su Q, Tan PX, Tang QL, Wang J, Huang G, Han J, Xu HW, et al: LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients. Tumour Biol. Feb 1–2017.(Epub ahead of print). doi.org/10.1177/1010428317691188. PubMed/NCBI
17	Chen X, Jia C, Jia C, Jin X and Gu X: MicroRNA-374a inhibits aggressive tumor biological behavior in bladder carcinoma by suppressing Wnt/β-catenin signaling. Cell Physiol Biochem. 48:815–826. 2018. View Article : Google Scholar : PubMed/NCBI
18	Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, Meng Z, Lin KC, Yu FX, Alexander CM, et al: Alternative Wnt signaling activates YAP/TAZ. Cell. 162:780–794. 2015. View Article : Google Scholar : PubMed/NCBI
19	Zhang LZ, Huang LY, Huang AL, Liu JX and Yang F: CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β catenin signaling pathway. Life Sci. 207:420–427. 2018. View Article : Google Scholar : PubMed/NCBI
20	Yu R, Cai L, Chi Y, Ding X and Wu X: miR-377 targets CUL4A and regulates metastatic capability in ovarian cancer. Int J Mol Med. 41:3147–3156. 2018.PubMed/NCBI
21	Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell metastasis. Mol Med Rep. 11:3108–3114. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wang YP, Guo PT, Zhu Z, Zhang H, Xu Y, Chen YZ, Liu F and Ma SP: Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma. Oncol Rep. 37:1961–1970. 2017. View Article : Google Scholar : PubMed/NCBI
23	Tang X, Zha L, Li H, Liao G, Huang Z, Peng X and Wang Z: Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Oncol Rep. 38:2023–2032. 2017. View Article : Google Scholar : PubMed/NCBI
24	Kim HJ, Moon SJ, Kim SH, Heo K and Kim JH: DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer. Cell Death Dis. 9:8312018. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Tao Y, Tao T, Gross N, Peng X, Li Y, Huang Z, Liu L, Li G, Chen X and Yang J: Combined effect of IL-12Rβ2 and IL-23R expression on prognosis of patients with laryngeal cancer. Cell Physiol Biochem. 50:1041–1054. 2018. View Article : Google Scholar : PubMed/NCBI
27	Chen J: The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med. 6:a0261042016. View Article : Google Scholar : PubMed/NCBI
28	Patil M, Pabla N and Dong Z: Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol Life Sci. 70:4009–4021. 2013. View Article : Google Scholar : PubMed/NCBI
29	Wang X, Zhu Y, Sun C, Wang T, Shen Y, Cai W, Sun J, Chi L, Wang H, Song N, et al: Feedback activation of basic fibroblast growth factor signaling via the Wnt/β-catenin pathway in skin fibroblasts. Front Pharmacol. 8:322017.PubMed/NCBI
30	Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J and He W: WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 345:206–217. 2016. View Article : Google Scholar : PubMed/NCBI
31	Johnson IT and Belshaw NJ: Environment, diet and CpG island methylation: Epigenetic signals in gastrointestinal neoplasia. Food Chem Toxicol. 46:1346–1359. 2008. View Article : Google Scholar : PubMed/NCBI
32	Hayden MS and Ghosh S: Regulation of NF-κB by TNF family cytokines. Semin Immunol. 26:253–266. 2014. View Article : Google Scholar : PubMed/NCBI
33	Yu L, Li L, Medeiros LJ and Young KH: NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. Blood Rev. 31:77–92. 2017. View Article : Google Scholar : PubMed/NCBI
34	Shukla S, Shankar E, Fu P, MacLennan GT and Gupta S: Suppression of NF-κB and NF-κB-regulated gene expression by apigenin through IκBα and IKK pathway in TRAMP mice. PLoS One. 10:e01387102015. View Article : Google Scholar : PubMed/NCBI
35	Prasad S, Ravindran J and Aggarwal BB: NF-kappaB and cancer: How intimate is this relationship. Mol Cell Biochem. 336:25–37. 2010. View Article : Google Scholar : PubMed/NCBI
36	Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
37	Dai G, Zheng D, Wang Q, Yang J, Liu G, Song Q, Sun X, Tao C, Hu Q, Gao T, et al: Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway. Oncotarget. 8:86098–86116. 2017. View Article : Google Scholar : PubMed/NCBI
38	Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D and Chun YJ: CYP1B1 enhances cell proliferation and metastasis through induction of EMT and activation of Wnt/β-catenin signaling via Sp1 upregulation. PLoS One. 11:e01515982016. View Article : Google Scholar : PubMed/NCBI
39	Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol. 172:973–981. 2006. View Article : Google Scholar : PubMed/NCBI